ZTOX

Ashok Leyland Forms Wholly-Owned Subsidiary in Indonesia

Ashok Leyland has incorporated a new wholly-owned subsidiary in Indonesia, marking a strategic corporate development for the commercial vehicle maker.

Ashok Leyland Sets Up Wholly-Owned Subsidiary in Indonesia

Ashok Leyland has incorporated a wholly-owned subsidiary in Indonesia, marking a strategic move to strengthen its footprint in the Southeast Asian market.

Ashok Leyland Sets Up Wholly-Owned Subsidiary in Indonesia

Ashok Leyland (ASHOKLEY) has incorporated a wholly-owned subsidiary in Indonesia, expanding its footprint in the Southeast Asian commercial vehicle market.

Ashok Leyland Sets Up Indonesia Subsidiary via BSE Filing

Ashok Leyland has disclosed the incorporation of a wholly-owned subsidiary in Indonesia through an official BSE filing, marking a strategic expansion into Southeast Asia.

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY2026

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share (18%) for FY2026, subject to approval at the upcoming Annual General Meeting.

Lincoln Pharmaceuticals Recommends ₹1.80 Final Dividend for FY26

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share for FY26, representing an 18% return on the Rs 10 face value.

SICALLOG

Market Updates Chartink scans

Sical Logistics Jumps 5%: Chartink Flags Unusual Trading Activity

Sical Logistics shares surge 4.99% to ₹68.80 as Chartink scans detect unusual trading activity—could signal a breakout for SICALLOG investors.

NAHARCAP

Nahar Capital Declares Rs 1.50 Final Dividend for FY26

Nahar Capital and Financial Services recommends Rs 1.50 final dividend per equity share for FY26. Board meeting held May 28, 2026.

Lincoln Pharmaceuticals Proposes Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals has proposed a final dividend of Rs 1.80 per equity share (18%) for the financial year ended March 31, 2026, awaiting shareholder approval at the ensuing AGM.

Lincoln Pharmaceuticals Recommends Rs 1.80 Final Dividend for FY26

Lincoln Pharmaceuticals has recommended a final dividend of Rs 1.80 per equity share (18%) for the financial year ended March 31, 2026.

NAHARSPING

Nahar Spinning Mills Announces Q4 FY2026 Financial Results

Nahar Spinning Mills Limited has disclosed its financial results for the period ended March 31, 2026, following a board meeting outcome submitted to the NSE.

NAHARSPING

Nahar Spinning Mills Files FY2026 Results: Board Meeting Outcome

Nahar Spinning Mills Limited (NAHARSPING) has submitted its financial results for the period ended March 31, 2026 to the NSE following a board meeting.

NAHARSPING